Results 71 to 80 of about 7,016,767 (306)

Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas, Jakob Q. Weiss, Kellee N. Parker, Cathy Lee‐Miller   +3 more
wiley   +1 more source

Organization of plant Biological Resource Centers for research in France: History, evolution and current status

Genetic Resources
Since their inception, the French academic organizations dedicated to agricultural research have developed plant collections in genebanks, often within a public–private framework, to support the study of plant traits and the development of new improved ...
Valerie Bergheaud, Jean-Marc Audergon, Arnaud Bellec, Anne Delaunay, Jérôme Duminil, Stéphane Dussert, Florence Esnault, Emmanuel Geoffriau, Brigitte Gouesnard, Christophe Jenny, Alain Label , Philippe Lashermes , Najate Maghnaoui, Cécile Marchal, Franciane Nuissier, Nilda Paulo-de-la-Réberdiere, Aurélia Priet, Valérie Riecau, Paule Térès, Anne-Françoise Adam-Blondon   +19 more
doaj   +1 more source

Administering Blinatumomab via Continuous Intravenous Infusion in Pediatric Patients—A Single‐Institution Retrospective Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley, Ryleigh Krueger, Kellie Joyce, James Stanley, Mary Waskerwitz‐Freyer, Marielle Klunder, David J. Hoogstra   +6 more
wiley   +1 more source

Genetics solutions for improved chicken production in Ghana

Genetic Resources
The Tropical Poultry Genetics Solutions project intervention in Ghana, a collaboration between the International Livestock Research Institute and the University of Ghana, with support from Ghana’s Ministry of Food and Agriculture, seeks to test the ...
Richard Osei-Amponsah, Ricky Aboagye Poku, Ebenezer Agyemang Duah, Augustine Naazie, Raphael Ayizanga, Harrisson Njamba, Wondmeneh Esatu, Mulugetta Yitayih Birhanu, Tadelle Dessie   +8 more
doaj   +1 more source

Evaluating the Readability of Patient‐Facing Online Educational Materials for Pediatric Leukemia and Lymphoma

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Together, leukemia and lymphoma account for 38.7% of newly diagnosed pediatric cancer cases in the United States each year. Many caregivers utilize online resources to inform medical health decisions. Understanding the readability of these materials is critical to ensuring comprehensible patient education.
Chloe Strege, Simone Intriago Tito, Courtney Popp, William C. Miller, Cindy Eide, Christen Ebens, Jakub Tolar   +6 more
wiley   +1 more source

Preserving, improving and rediscovering: The role of the Research Centre of Viticulture and Enology in safeguarding grapevine genetic resources in Italy

Genetic Resources
Grapevine is one the most cultivated species worldwide, with 8,000 estimated varieties. Protecting this biodiversity is of utmost importance, especially in countries historically devoted to viticulture, such as Italy.
Maria Antonietta Palombi, Vittorio Alba, Marco Ammoniaci, Noemi Bevilacqua, Angelo Raffaele Caputo, Roberto Carraro, Stefano Favale, Simone Garavelloni, Massimo Gardiman, Massimo Morassut, Marina Niero, Roberto Nuti, Giuseppina Pipitone, Sergio Puccioni, Alessandra Zombardo   +14 more
doaj   +1 more source

Improvement of Sickle Cell Disease Care Mitigates the Healthcare Utilization Induced by Increased Prevalence: Experience of a Tertiary Pediatric Center

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) has undergone major changes in the last decades. Its prevalence has been steadily increasing and numerous advances have been made in the management of the disease. However, the effect in real‐life setting of these major changes is unknown, particularly in a Canadian environment. Procedure We aimed to assess
Maude Cigna, Alexia Muresan, Estelle Lecluze, Karine Leduc, Nathalie Fournier, Maria Tamer, Jean‐François Delisle, Jeremi Charbonneau, Annie Viau, Jessica Darilus, Marie‐Joëlle Doré‐Bergeron, Valérie Arsenault, Evelyne Doyon‐Trottier, Stéphanie Forte, Nancy Robitaille, Yves Pastore, Thomas Pincez   +16 more
wiley   +1 more source

Combined cytogenetic and molecular methods for taxonomic verification and description of Brassica populations deriving from different origins

Genetic Resources
Agriculture faces great challenges to overcome global warming and improve system sustainability, requiring access to novel genetic diversity. So far, wild populations and local landraces remain poorly explored.
Cyril Falentin, Houria Hadj-Arab, Fella Aissiou, Claudia Bartoli, Giuseppe Bazan, Matéo Boudet, Lydia Bousset-Vaslin, Marwa Chouikhi, Olivier Coriton, Gwénaelle Deniot, Julie Ferreira de Carvalho, Laurène Gay, Anna Geraci, Pascal Glory, Virginie Huteau, Riadh Ilahy, Vincenzo Ilardi, José A. Jarillo, Vladimir Meglic, Elisabetta Oddo, Monica Pernas, Manuel Pineiro, Barbara Pipan, Thouraya Rhim, Vincent Richer, Fulvia Rizza, Joelle Ronfort, Mathieu Rousseau-Gueutin, Rosario Schicchi, Lovro Sinkovic, Maryse Taburel, Valeria Terzi, Sylvain Théréné, Mathieu Tiret, Imen Tlili, Marie-Hélène Wagner, Franz Werner Badeck, Anne-Marie Chèvre   +37 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun   +4 more
wiley   +1 more source